- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06418269
The Effect of Therapeutic Play on Anxiety and Fear Levels in Children With Diabetes
The Effect of Insulin Education Given to Children With Diabetes by Therapeutic Play Method on Anxiety and Fear Levels
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Excessive stress and anxiety experienced by children can affect their physical and physiological health and hinder their ability to cope with medical interventions. Pain and negative emotions associated with blood sampling or insulin administration can negatively affect children's diabetes self-care skills and may lead to avoidance of injections.
Play-based interventions allow the child to process potentially frightening events and correct misconceptions about an illness and its management. Overall, therapeutic play interventions have been effective in reducing the child's pain, anxiety and stress while encouraging cooperation. Since insulin treatment (subcutaneous) causes fear and anxiety in children, the aim of this study was to reduce fear and anxiety by dramatization method by storytelling the child's procedure and disease with the game of administering insulin treatment (subcutaneous) to a doll.
In the Pediatric Endocrinology Service, children between the ages of 9 and 12 years who have just been diagnosed with Type 1 diabetes and who meet the sample selection criteria and their parents will be met and informed about the study and written and verbal consent will be obtained from the children and their parents who volunteer to participate in the study. Children will be asked to fill out the "Child Patient Identification Form", "State Anxiety Scale in Children" and "Child Fear Scale" 30 minutes before insulin treatment. Then, the children will be randomized by the researcher and assigned to two different groups as experimental and control groups. Before the insulin treatment procedure, the children in the experimental group will be made to take blood glucose and administer insulin on a doll with the therapeutic play method. The children in the control group will receive the routine treatment of the clinic. Within 10 minutes after subcutaneous insulin treatment, the child will be asked to fill out the "State Anxiety Scale in Children" and "Child Fear Scale".
Therapeutic Play Content: The doll to be used in the study represents the sick children in the experimental group. The child will be told that the doll has been hospitalized with a diagnosis of Type 1 diabetes and will be expected to assume the role of a nurse in order to administer insulin to the doll. The materials to be used during insulin administration will be introduced to the child and the child will be made to recognize the materials more closely. Then, the steps of blood glucose measurement and insulin treatment (subcutaneous) will be explained to the child and the child will be asked to apply the insulin to the doll.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Canan Genç, MSc
- Phone Number: 5372828808
- Email: cananuzun5561@gmail.com
Study Contact Backup
- Name: Nermin Eroğlu, PhD
- Email: nermin.guduloglu20@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The child must be between the ages of 9 and 12 (since the State Anxiety Inventory for Children Scale is for this age range)
- Diagnosed with type 1 diabetes
- Absence of mental retardation
- Receiving subcutaneous insulin treatment for the first time
- Voluntariness of the child and parent to participate in the study
Exclusion Criteria:
- Visual, hearing or speech impairment
- Illiteracy of the child
- Having a clinical condition that prevents playing games (excessive fatigue, weakness, etc.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control Group
|
|
Experimental: Therapeutic Play Group
|
Children will be asked to fill in the "Child Patient Identification Form", "State Anxiety Scale in Children" and "Child Fear Scale" 30 minutes before insulin treatment.
Before the insulin treatment, the children in the experimental group will have their blood glucose measured and insulin administered on a doll using the therapeutic play method.
The child will be told that the doll is hospitalized with a diagnosis of Type 1 diabetes and will be expected to assume the role of a nurse to administer insulin to the doll.
Then, the steps of blood glucose measurement and insulin treatment (subcutaneous) will be explained to the child and the child will be asked to administer insulin to the baby.
Within 10 minutes after subcutaneous insulin treatment, the child will be asked to fill out the "State Anxiety Scale in Children" and "Child Fear Scale".
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
State-Trait Anxiety Inventory for Children
Time Frame: 30 minutes before insulin treatment, within 10 minutes after subcutaneous insulin treatment
|
Anxiety states of children that may occur due to subcutaneous insulin treatment will be evaluated.
The lowest score that can be obtained from the State Anxiety Scale is 20 and the highest score is 60.
|
30 minutes before insulin treatment, within 10 minutes after subcutaneous insulin treatment
|
Child Fear Scale
Time Frame: 30 minutes before insulin treatment, within 10 minutes after subcutaneous insulin treatment
|
Fear states of children that may occur due to subcutaneous insulin treatment will be evaluated.
In this method, the child is shown a picture with five facial expressions rated between 0 and 4. 0 indicates no fear and anxiety, while 4 indicates the highest fear and anxiety.
|
30 minutes before insulin treatment, within 10 minutes after subcutaneous insulin treatment
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 53.2024fbu
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type1diabetes
-
Silesian Centre for Heart DiseasesThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedtype1diabetesPoland
-
Vastra Gotaland RegionCompletedType1diabetesSweden
-
Rabin Medical CenterThe Leona M. and Harry B. Helmsley Charitable Trust; DreaMed DiabetesRecruiting
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustCompletedType1diabetesUnited States
-
Radboud University Medical CenterUnknownType1diabetes | Hypoglycemia UnawarenessNetherlands
-
Aalborg University HospitalAalborg University; Steno Diabetes Center NordjyllandCompletedType1diabetes | Hemodialysis | Type2DiabetesDenmark
-
Vastra Gotaland RegionActive, not recruitingType1diabetes | Psychology Functional BehaviorSweden
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruitingHypoglycemia | Type1diabetes | Islet Cell Transplantation | Hypoglycemia UnawarenessUnited States
-
University of British ColumbiaJuvenile Diabetes Research Foundation; Brain CanadaNot yet recruiting
Clinical Trials on Therapeutic Play
-
Ataturk UniversityRecruiting
-
Eskisehir Osmangazi UniversityRecruiting
-
Aydin Adnan Menderes UniversityCompletedAnxiety | FearTurkey
-
Maltepe UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Aydin Adnan Menderes UniversityCompleted
-
Maharishi Markendeswar University (Deemed to be...Completed
-
Seattle Children's HospitalNational Cancer Institute (NCI)Completed
-
San Diego State UniversityUniversity of Southern CaliforniaCompleted
-
University of Colorado, DenverRecruitingDental Anxiety | Dental Phobia | Oral AversionUnited States